KR100325584B1 - The composites of raw-type tea with anti-diabetic function - Google Patents
The composites of raw-type tea with anti-diabetic function Download PDFInfo
- Publication number
- KR100325584B1 KR100325584B1 KR1020000062365A KR20000062365A KR100325584B1 KR 100325584 B1 KR100325584 B1 KR 100325584B1 KR 1020000062365 A KR1020000062365 A KR 1020000062365A KR 20000062365 A KR20000062365 A KR 20000062365A KR 100325584 B1 KR100325584 B1 KR 100325584B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- zinc
- germinated
- vitamin
- diabetes
- Prior art date
Links
- 239000003472 antidiabetic agent Substances 0.000 title claims abstract description 15
- 230000003178 anti-diabetic effect Effects 0.000 title claims abstract description 11
- 241001122767 Theaceae Species 0.000 title 1
- 239000002131 composite material Substances 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 28
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 27
- 240000000249 Morus alba Species 0.000 claims abstract description 26
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 26
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000011575 calcium Substances 0.000 claims abstract description 25
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 25
- 229940038879 chelated zinc Drugs 0.000 claims abstract description 21
- 230000001850 reproductive effect Effects 0.000 claims abstract description 17
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 15
- 239000011718 vitamin C Substances 0.000 claims abstract description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims abstract description 12
- 239000000835 fiber Substances 0.000 claims description 16
- 235000010469 Glycine max Nutrition 0.000 claims description 13
- 235000021329 brown rice Nutrition 0.000 claims description 13
- 230000035784 germination Effects 0.000 claims description 12
- 241001474374 Blennius Species 0.000 claims description 11
- 240000007124 Brassica oleracea Species 0.000 claims description 9
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 9
- 239000005862 Whey Substances 0.000 claims description 9
- 102000007544 Whey Proteins Human genes 0.000 claims description 9
- 108010046377 Whey Proteins Proteins 0.000 claims description 9
- 240000005979 Hordeum vulgare Species 0.000 claims description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 5
- 240000006891 Artemisia vulgaris Species 0.000 claims description 5
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims description 5
- 235000002767 Daucus carota Nutrition 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 5
- 240000000599 Lentinula edodes Species 0.000 claims description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 5
- 235000011613 Pinus brutia Nutrition 0.000 claims description 5
- 241000018646 Pinus brutia Species 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 240000001417 Vigna umbellata Species 0.000 claims description 5
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 229940010454 licorice Drugs 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229940109850 royal jelly Drugs 0.000 claims description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 4
- 235000000832 Ayote Nutrition 0.000 claims description 4
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 4
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 4
- 240000004244 Cucurbita moschata Species 0.000 claims description 4
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 4
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 4
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 4
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 4
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 244000088415 Raphanus sativus Species 0.000 claims description 4
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 240000003829 Sorghum propinquum Species 0.000 claims description 4
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 4
- 235000015136 pumpkin Nutrition 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 235000007215 black sesame Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 241001107116 Castanospermum australe Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 239000011324 bead Substances 0.000 claims 1
- 235000021279 black bean Nutrition 0.000 claims 1
- 238000010411 cooking Methods 0.000 claims 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 62
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 59
- 239000011701 zinc Substances 0.000 abstract description 59
- 229910052725 zinc Inorganic materials 0.000 abstract description 59
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 44
- 102000004877 Insulin Human genes 0.000 abstract description 31
- 108090001061 Insulin Proteins 0.000 abstract description 31
- 229940125396 insulin Drugs 0.000 abstract description 31
- 235000001465 calcium Nutrition 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 18
- 238000010521 absorption reaction Methods 0.000 abstract description 15
- 239000013522 chelant Substances 0.000 abstract description 9
- 102000015636 Oligopeptides Human genes 0.000 abstract description 8
- 108010038807 Oligopeptides Proteins 0.000 abstract description 8
- 230000004913 activation Effects 0.000 abstract description 6
- 235000013325 dietary fiber Nutrition 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 230000007812 deficiency Effects 0.000 abstract description 4
- 235000013311 vegetables Nutrition 0.000 abstract description 2
- 230000005070 ripening Effects 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 23
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 20
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 235000000346 sugar Nutrition 0.000 description 19
- 229910052500 inorganic mineral Inorganic materials 0.000 description 18
- 239000011707 mineral Substances 0.000 description 18
- 235000010755 mineral Nutrition 0.000 description 18
- 235000018102 proteins Nutrition 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 229930003231 vitamin Natural products 0.000 description 12
- 235000013343 vitamin Nutrition 0.000 description 12
- 239000011782 vitamin Substances 0.000 description 12
- 229940088594 vitamin Drugs 0.000 description 12
- 229910052742 iron Inorganic materials 0.000 description 10
- 150000001720 carbohydrates Chemical class 0.000 description 9
- 235000014633 carbohydrates Nutrition 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000003925 fat Substances 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 208000017169 kidney disease Diseases 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 241000512259 Ascophyllum nodosum Species 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 235000014786 phosphorus Nutrition 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 241000255789 Bombyx mori Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 description 5
- 108010012715 Superoxide dismutase Proteins 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 208000018522 Gastrointestinal disease Diseases 0.000 description 4
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000002075 main ingredient Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 4
- 229940013618 stevioside Drugs 0.000 description 4
- 235000019202 steviosides Nutrition 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 229910001656 zinc mineral Inorganic materials 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 229940126904 hypoglycaemic agent Drugs 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 235000007686 potassium Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 2
- 235000003097 Artemisia absinthium Nutrition 0.000 description 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000001138 artemisia absinthium Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- -1 B 2 Substances 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 108010076181 Proinsulin Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000005499 Sasa Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 230000000667 effect on insulin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000009229 glucose formation Effects 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000022934 urinary frequency Diseases 0.000 description 1
- 230000036318 urination frequency Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Abstract
본 발명은 킬레이트 아연이 첨가된 차(茶) 조성물에 관한 것이다.The present invention relates to a tea composition to which chelated zinc is added.
본 발명은 킬레이트 아연(chelate zinc) 등이 함유된 항당뇨 기능의 차(茶) 조성물에 관한 것으로서, 더욱 상세하게는 인슐린 활성에 영향을 주지만 신체 내에서 그 흡수 이용률이 매우 낮은 아연을 올리고 펩티드로 킬레이트화시킨 킬레이트 아연으로 제조하여 곡식류 또는 채소류 등을 익히지 않고 건조 분말화한 후 물에 타서 음용하는 생식 타입의 차에 첨가한 항당뇨 기능의 생식 타입 차 조성물에 관한 것이다.The present invention relates to an anti-diabetic tea composition containing chelate zinc and the like, and more particularly, to a zinc oligopeptide which affects insulin activity but has a very low absorption rate in the body. The present invention relates to an anti-diabetic reproductive type tea composition prepared by chelating zinc chelated zinc and dried and powdered without ripening grains or vegetables, and then added to a reproductive type tea drinkable in water.
따라서 본 발명에 따른 차 조성물은 당뇨 타입 중 가장 큰 비중을 차지하는 인슐린 활성화 부족 타입 당뇨의 발병 원인 중의 하나인 아연 흡수 부족을 해소할 수 있도록 하였으며, 이외에도 당뇨에 유용한 뽕잎, 식이 섬유, 비타민 B1,비타민 B6, 비타민 C, 칼슘 등을 배합하여 제조함으로써 당뇨병 치료에 효과적으로 이용될 수 있게 하였다.Therefore, the tea composition according to the present invention was able to solve the zinc absorption deficiency, which is one of the causes of insulin activation deficiency type diabetes, which occupies the largest proportion of diabetes type, and mulberry leaf, dietary fiber, vitamin B 1, Vitamin B 6 , vitamin C, and calcium are formulated to make it effective for treating diabetes.
Description
본 발명은 킬레이트 아연이 첨가된 차(茶) 조성물에 관한 것이다.The present invention relates to a tea composition to which chelated zinc is added.
본 발명은 킬레이트 아연(chelate zinc, 일명 단백 아연 또는 아연 올리고 펩티드라고도 함) 등이 첨가된 항당뇨 기능의 차 조성물에 관한 것으로, 아연의 체내 흡수 및 이용률을 높인 킬레이트 아연과 당뇨에 효과적인 뽕잎, 식이 섬유, 비타민, 칼슘 등을 생식 타입의 차에 첨가하여 당뇨 환자들이 유용하게 음용할 수 있도록 한 것이다.The present invention relates to an anti-diabetic tea composition to which chelate zinc (also known as protein zinc or zinc oligo peptide) is added, and is effective in chelate zinc and diabetes, which have increased absorption and utilization of zinc in the body, and mulberry leaves and diet. Fiber, vitamins, and calcium were added to the reproductive type of tea to make it more useful for diabetics.
당뇨병이란 뜻 그대로 풀이한다면 소변 속에 당이 나온다는 뜻이며, 음식물을 적절하게 우리 몸에서 사용하지 못하여 혈액 속에 포도당(Glucose)의 농도가 너무 높아져 일어나는 질병을 말한다. 일반적으로 탄수화물 성분의 음식물이 우리 몸으로 들어오게 되면 1∼5분 이내에 포도당(glucose)으로 전환되고, 췌장에서는 혈관 속의 포도당이 세포로 들어가는데 열쇠 역할을 하는 인슐린을 만들어 내며 세포 속에 들어간 포도당은 에너지원으로 쓰이게 된다.Diabetes, if you mean it, means sugar in the urine, and the food is not used properly in our bodies because of too high glucose (Glucose) concentration in the blood. In general, when carbohydrate-containing food enters our body, it is converted into glucose within 1 to 5 minutes. In the pancreas, glucose in blood vessels makes insulin, which is the key to getting into cells. It is used as.
인슐린은 췌장의 랑게르한스(Langerhans)선의 베타 세포에서 만들어지는 단백질성 호르몬이며 혈액 중에 분비되는 호르몬으로 온몸에 분포되어 있으며 혈액 중에서 당, 지질, 아미노산 대사를 조절하고 또 간장, 근육, 지방 조직에 당의 저장을 촉진하며 근육에서 아미노산의 흡수를 조장하는 것으로 알려져 있다.Insulin is a protein hormone produced by the beta cells of the Langerhans gland of the pancreas. It is a hormone secreted from the blood and distributed throughout the body. It regulates the metabolism of sugars, lipids and amino acids in the blood, and stores sugars in the liver, muscle and adipose tissue. Is known to promote the absorption of amino acids in muscles.
이러한 인슐린이 체내의 혈당량을 조절하는데 있어서 그 양이 정상이면 흡수된 당이 다소 많아도 체내 이용을 촉진함으로써 혈당량을 정상적으로 유지할 수 있지만, 인슐린의 작용이 활발하지 못한 상태에서는 세포내의 당의 흡수가 정상적으로 이루어지지 못하므로 혈액 속의 당이 증가하게 되는 것이다. 이처럼 인슐린의 양이 부족하거나 인슐린 활성이 부족한 것이 당뇨이며, 이 중에서도 당뇨 발병의 가장 큰 비중을 차지하는 것이 인슐린 활성 부족에 의한 것이다. 이와 같은 인슐린 활성 부족의 원인으로는 아연 미네랄(zinc mineral)의 부족이 결정적인 것으로 보고되고 있다. 즉, 체내에서 당의 이용과 인슐린의 관계는 절대적이며 또한 인슐린의 활성은 아연 미네랄의 도움 없이는 불가능한데 그 이유는 아연이 인슐린 분자 내에 결합된 상태로 존재하기 때문이다.If the amount of insulin is normal in the body to control blood glucose levels, even though a large amount of sugar is absorbed, the blood sugar can be maintained normally by promoting the use of the body, but in the state where the action of insulin is not active, the absorption of sugar in the cell is not normal. Because it does not increase the sugar in the blood. As such, the lack of insulin or lack of insulin activity is diabetes, and the most important part of the onset of diabetes is due to lack of insulin activity. The deficiency of zinc minerals (zinc minerals) is reported to be the cause of such a lack of insulin activity. In other words, the relationship between the use of sugar and insulin in the body is absolute, and the activity of insulin is impossible without the help of zinc minerals because zinc exists in the insulin molecule.
아연은 인체를 구성하고 있는 극미량 원소이자 성장, 번식 및 재생 등에 관여하는 미네랄로 하루 15mg 정도가 필요하다. 75kg 성인은 1.5∼2.3g의 아연을 함유하고 있는 것으로 추정되며 정상적인 사람의 경우 신체 부위에 따라 다른데, 전립선에 100㎍/g 정도, 근육에는 50㎍/g 정도로 가장 많이 분포되어 있다.Zinc is a trace element constituting the human body and a mineral involved in growth, reproduction and regeneration, and needs about 15mg per day. The 75kg adult is estimated to contain 1.5-2.3g of zinc, which depends on the part of the body in normal humans. The most common distribution is about 100µg / g in the prostate and about 50µg / g in the muscles.
또한 아연은 인슐린의 활성 뿐만 아니라 DNA 합성에도 없어서는 안되는 미네랄이며, 지금까지 알려진 아연의 기능만 보더라도 단백질 합성, 조직 생성과 성장, 인슐린의 활성화, 남성 생식기의 성장과 강화, 탈모 방지 등 다양하다. 운동 선수들은 보통 사람보다 20배나 많은 아연을 가지고 있으며 그 이유는 아연이 인슐린의 활성을 촉진하여 포도당을 잘 연소시켜 주어 에너지 발생을 촉진하기 때문이다.In addition, zinc is an indispensable mineral not only for insulin activity but also for DNA synthesis, and it is also known that zinc is known to have various functions such as protein synthesis, tissue formation and growth, insulin activation, male genital growth and strengthening, and hair loss prevention. Athletes have 20 times more zinc than ordinary people because zinc stimulates insulin activity and burns glucose well, accelerating energy generation.
정상적인 사람은 인슐린을 분비하여 주는 췌장의 베타 세포에 100∼1000ppm의 아연을 가지고 있으며 인슐린 내에도 0.15∼3% 이상의 아연을 분자 구조로 함유하고 있다.Normal humans have 100 to 1000 ppm of zinc in the beta cells of the pancreas that secrete insulin, and 0.15 to 3% or more of zinc is contained in insulin as a molecular structure.
또한 활성 산소는 인체 내의 각종 기관 특히 베타 세포를 공격하여 파괴하므로 당뇨의 원인이 되기도 하는데 이 활성산소를 제거해 주는 효소가 SOD(superoxide dismutase)이며 이 SOD의 분자 구조에도 아연이 함유되어 있기 때문에 아연의 부족은 SOD 생성을 방해하여 당뇨를 더 악화시키는 원인이 되기도 한다.In addition, free radicals attack and destroy various organs in the body, especially beta cells, which can cause diabetes. The enzyme that removes free radicals is SOD (superoxide dismutase), and since the molecular structure of SOD contains zinc, Deficiency can also interfere with SOD production and make diabetes worse.
이와 같이 아연이 체외로부터 조달되어 체내에서 흡수되어야 인슐린이 만들어지고 당뇨병 발생을 방지할 수 있는데 아연은 흡수 조건이 까다로워 항상 부족되기 쉬운 상태에 있다. 더구나 요즈음의 풍부한 식사 패턴은 많은 양의 탄수화물과 지방, 단백질을 섭취하게 만드는 반면에 미네랄 흡수와 활성을 가장 저해하는 요소인 지방 섭취와 인(phosphorus) 성분의 섭취가 급속도로 증가하게 되었다.In this way, zinc must be procured from the outside and absorbed in the body to make insulin and prevent the occurrence of diabetes. What's more, today's rich eating patterns lead to high amounts of carbohydrates, fats, and proteins, while rapidly increasing the intake of fat and phosphorus, which are the most damaging agents for mineral absorption and activity.
최근 통계에 의하면 지방질은 과거의 5배, 인산염은 각종 청량 음료에 함유된 인산염 섭취의 증가로 과거의 100배나 섭취가 증가되어 아연 미네랄 결핍 현상이 날로 증대되어 당뇨병 환자의 증가를 부채질하고 있다.According to the recent statistics, fat is five times the past, phosphate is the increase in phosphate intake in various soft drinks 100 times in the past, zinc mineral deficiency is increasing day by day, which contributes to the increase in diabetics.
한편 당뇨병 환자들은 아연을 전혀 가지고 있지 않거나 상당히 부족한 상태임이 밝혀졌는데, 이와 같은 현상을 알고 있으면서도 즉각 대응하지 못하는 것은일반 미네랄 상태의 아연은 과량 섭취시 위장 장해나 인체 내 축적으로 건강을 오히려 해치게 되는 결과를 초래할 수 있어 어쩔 수 없이 당뇨병 환자들에게 혈당 강하제를 권하고 있지만, 혈당 강하제의 부작용을 우려한 나머지 식이 요법을 우선적으로 선택하도록 권하는 등 근본적인 치료를 하지 못하고 있는 것이 현재의 실정이다.On the other hand, diabetics have been found to have no zinc or a very low level. However, even when they are aware of this phenomenon, they do not respond immediately. In general, zinc in the form of minerals harms health due to gastrointestinal disorders or accumulation in the human body. Although it is inevitable to recommend diabetic patients to hypoglycemic drugs, the current situation is that they are not able to fundamentally treat such as recommending to choose a diet in consideration of the side effects of hypoglycemic agents.
그러나 식이 요법은 당의 섭취를 적게 하도록 하는 일시적인 방법일 뿐 치료 목적은 아니다. 현재의 치료 방법으로는 인슐린과 아연 인슐린, 혈당 강하제가 이용되고 있지만 근본 치료가 아닌 대중 요법으로 일시적인 증상만을 감소시키는 역할을 하고 있으며 부작용도 상당한 것으로 알려져 있다.However, diet is a temporary measure of low sugar intake, not a therapeutic goal. Current methods of treatment include insulin, zinc insulin, and hypoglycemic agents, but they are known to reduce the temporary symptoms only by popular therapies rather than the basic treatments.
혈당 강하제의 작용은 간장과 조직에 있는 간 글리코겐과 근육 글리코겐으로부터 포도당의 생성을 억제하는 것으로 알려져 있을 뿐 인슐린에 대한 직접적인 영향에는 분명하지 않고, 또한 이들 치료제는 계속 사용되고 있으나 모두 일시적인 방법일 뿐 정상으로 회복시킬 수 없는 것이 현실이다.The action of hypoglycemic agents is known to inhibit glucose production from hepatic and muscle glycogen and hepatic glycogen in the liver and tissues, but it is not obvious to the direct effects on insulin. The reality is that it cannot be recovered.
또한 국내의 당뇨 환자용 건강 식품의 특허 출원 내용을 살펴본 결과 당뇨에 효험이 있다고 알려진 인삼, 상백피, 오미자, 오리나무 등의 일부 약초나 한약재등을 이용하여 일시적인 혈당 강하 효과를 이용하고자 하는 내용이 대부분이고 당뇨의 근본적인 원인인 인슐린 활성화와 관련된 물질의 이용은 전무한 실정이다.In addition, as a result of examining the patent application contents of the health food for diabetic patients in Korea, most of the contents are intended to take advantage of the temporary hypoglycemic effect by using some herbs or herbal medicines such as ginseng, baekbaekpi, Schisandra chinensis and alder, which are known to be effective in diabetes. There is no use of substances related to insulin activation, which is a fundamental cause of diabetes.
본 발명은 상기한 문제점을 고려하여 안출된 것으로서, 본 발명의 목적은 당뇨 환자의 인슐린 활성화에 영향을 미치는 아연을 올리고 펩티드 형태의 단백질로킬레이트화시켜 세포 내로 흡수 및 이용을 용이하게 한 킬레이트 아연과 당뇨에 유용한 뽕잎, 식이 섬유, 비타민, 칼슘 등을 생식 타입의 차에 첨가하여 당뇨 증상을 개선시킬 수 있고 당뇨 환자들이 쉽게 음용할 수 있도록 한 항당뇨 기능의 생식 타입 차 조성물을 제공하는 데 있다.SUMMARY OF THE INVENTION The present invention has been made in view of the above problems, and an object of the present invention is to chelate zinc that affects insulin activation in diabetic patients with chelated zinc, which facilitates absorption and utilization into cells by chelating zinc into proteins in the form of peptides. Mulberry leaves, dietary fiber, vitamins, calcium, etc., which are useful for diabetes, can be added to a reproductive type tea to improve the symptoms of diabetes and provide an anti-diabetic reproductive type tea composition that can be easily consumed by diabetic patients.
이와 같은 목적을 달성하기 위해서 본 발명에 따른 항당뇨 기능의 생식 타입 차 조성물은 인슐린 활성에 영향을 주지만 신체 내에서 그 흡수 이용률이 매우 낮은 아연을 올리고 펩티드로 킬레이트화시킨 킬레이트 아연으로 제조하여 곡식류 또는 채소류 등을 익히지 않고 건조 분말화한 후 물에 타서 음용하는 생식 타입의 차에 첨가한 것을 특징으로 하는 것으로서, 당뇨 타입 중 가장 큰 비중을 차지하는 인슐린 활성화 부족 타입 당뇨의 발병 원인 중의 하나인 아연 흡수 부족을 해소할 수 있도록 하였으며, 이외에도 당뇨에 유용한 뽕잎, 식이 섬유, 비타민 B1,비타민 B6, 비타민 C, 칼슘 등을 배합하여 제조함으로써 당뇨병 치료에 효과적으로 이용될 수 있게 하였다.In order to achieve the above object, the reproductive type tea composition of the anti-diabetic function according to the present invention is made of chelated zinc obtained by chelating zinc with an oligopeptide which has an effect on insulin activity but has a very low absorption rate in the body. It is characterized in that it is added to raw food type teas that are dried and powdered without being cooked and then cooked in water. Insufficient zinc absorption, which is one of the causes of the development of insulin activation type diabetes, which accounts for the largest proportion of diabetes types. In addition, the mulberry leaf, dietary fiber, vitamin B 1, vitamin B 6 , vitamin C, calcium, etc., which are useful for diabetes, can be used to effectively treat diabetes.
이하 본 발명을 상세하게 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 항당뇨 기능의 차 조성물은 발아 현미 59.0∼83.0중량%, 발아 보리 1.0∼8.0중량%, 발아 검정콩 0.1∼0.5중량%, 발아 율무 0.05∼0.3중량%, 발아 수수 0.5∼1.5중량%, 발아 옥수수 0.5∼5.0중량%, 발아 차조 0.2∼2.0중량%, 발아 팥 0.3∼0.8중량%, 발아 검정깨 0.05∼0.35중량%, 발아밀 0.1∼0.3중량%, 킬레이트 아연 0.03∼5.0중량%, 뽕잎 0.5∼5.0중량%, 케일 0.1∼0.5중량%, 명일엽 0.1∼0.5중량%, 다시마 0.1∼3.0중량%, 미역 0.2∼1.8중량%, 김 0.02∼0.24중량%, 쑥 0.3∼0.7중량%, 표고 버섯 0.05∼0.35중량%, 당근 0.05∼0.5중량%, 솔잎 0.05∼0.3중량%, 미강 0.05∼2.0중량%, 감자 0.1∼0.3중량%, 메밀 0.1∼1.0중량%, 늙은 호박 0.05∼0.8중량%, 양배추 0.05∼0.35중량%, 무 0.01∼0.5중량%, 석이 버섯 0.1∼1.2중량% 등을 각각 익히지 않고 생으로 건조하여 분말로 한 것과 로얄 젤리 0.01∼0.5중량%, 감초 0.2∼1.6중량%, 젖산 효모 0.4∼1.2중량%, 스테비오 사이드 0.01∼0.04중량%로 구성되는 것을 특징으로 한다.Tea composition of the anti-diabetic function according to the present invention is 59.0 to 83.0% by weight of germinated brown rice, 1.0 to 8.0% by weight of germinated barley, 0.1 to 0.5% by weight of germinated black soybean, 0.05 to 0.3% by weight of germination rate, 0.5 to 1.5% by weight of germination , Germinated corn 0.5-5.0 wt%, germinated tea 0.2-2.0 wt%, germinated red bean 0.3-0.8 wt%, germinated black sesame 0.05-0.35 wt%, germinated wheat 0.1-0.3 wt%, chelated zinc 0.03-5.0 wt%, Mulberry leaf 0.5-5.0%, kale 0.1-0.5%, light day 0.1-0.5%, kelp 0.1-3.0%, seaweed 0.2-1.8%, seaweed 0.02-0.24%, mugwort 0.3-0.7%, altitude Mushroom 0.05 ~ 0.35%, Carrot 0.05 ~ 0.5%, Pine needles 0.05 ~ 0.3%, Rice bran 0.05 ~ 2.0%, Potato 0.1 ~ 0.3%, Buckwheat 0.1 ~ 1.0%, Old pumpkin 0.05 ~ 0.8%, Cabbage 0.05 to 0.35% by weight, radish 0.01 to 0.5% by weight, shiitake mushrooms 0.1 to 1.2% by weight without drying, respectively, powdered and royal jelly 0.01 to 0.5% by weight, licorice 0.2 1.6% by weight, lactic yeast 0.4 to 1.2 characterized in that consisting of% by weight, stevioside 0.01~0.04% by weight.
또한 상기 조성물에 비타민 B10.005∼0.05중량%, 비타민 B60.01∼0.1중량%, 비타민 C 0.05∼1.0중량%, 콩 섬유질 0.5∼2.5중량%, 유청 칼슘 0.2∼5.0중량%를 더욱 첨가하여 그 효능을 강화시킬 수 있다.In addition, 0.005 to 0.05% by weight of vitamin B 1 , 0.01 to 0.1% by weight of vitamin B 6 , 0.05 to 1.0% by weight of vitamin C, 0.5 to 2.5% by weight of soy fiber, and 0.2 to 5.0% by weight of whey calcium were added to the composition. It can enhance efficacy.
본 발명에서 조성물로서 배합되는 킬레이트 아연은 혼합 발효 탱크 내에서 아연을 올리고 펩티드와 킬레이트 결합하도록 특정 조건에서 발효 및 반응시킨 것으로서 평균 분자량은 800∼1000 정도이며 이 중에 순수 아연(Zn)은 6∼8중량%가 함유되어 있고, 인습성이 강하고 약간의 신맛과 효모맛이 나는 미황색 분말이다.The chelated zinc compounded as a composition in the present invention is fermented and reacted under specific conditions to raise the zinc and chelate the peptide in a mixed fermentation tank, and has an average molecular weight of about 800 to 1000, of which pure zinc (Zn) is 6 to 8 It is a pale yellow powder that contains by weight, strong moisture, and has a slight sour and yeast taste.
앞서 설명한 것과 같이 당뇨 원인 중 가장 큰 비중을 차지하는 인슐린 활성 부족형 당뇨는 주로 아연 부족 때문인 것으로 알려져 있다. 인슐린의 분자량 6065 중 아연을 빼면 6000이 되는데 이렇게 아연이 부족한 인슐린을 프로 인슐린(proinsulin)이라 하고 이러한 프로 인슐린은 활성이 부족하여 인슐린 역할을 할 수 없어 당뇨병인 걸리게 된다. 참고로 인슐린 분자내의 아연의 결합 구조를 화학식 1에 나타내었다.As described above, insulin-inactive diabetes, which accounts for the largest proportion of diabetes, is known to be mainly due to zinc deficiency. When the zinc molecular weight of 6065 is subtracted from zinc, it becomes 6000. Insulin that lacks zinc is called proinsulin, and these proinsins are not active enough to act as insulin and become diabetic. For reference, the binding structure of zinc in the insulin molecule is shown in Chemical Formula 1.
인슐린 분자 내의 아연의 결합 구조Binding structure of zinc in insulin molecule
즉 아연이 풍부하면 아연의 도움으로 인슐린을 활성화시켜 당을 연소시킬 것이고 당의 연소는 에너지 발생으로 직결되어 신체적 활력을 가져오게 되며 당뇨병이 치료된다.In other words, if zinc is rich, it activates insulin with the help of zinc to burn sugar, and the burning of sugar directly leads to energy generation, bringing physical vitality and treating diabetes.
그러나 당뇨병의 근본적인 원인은 소장의 흡수막이 아연을 용이하게 흡수하지 못하는 데에 있다. 신체 조직은 나이가 들면서 영양분의 흡수는 물론이고 미네랄의 흡수도 어렵게 되는데, 여기에 서구화된 가공 식품 위주의 식습관이 아연 흡수를 저해하여 체내 아연 공급이 어렵게 되며, 일반 아연의 경우 흡수 이용률이 2∼3%로 극히 낮고 또한 흡수량을 높이기 위해 과량을 섭취할 경우에는 체내에 축적되어 독성을 발휘하기 때문에 용이하게 체내의 아연 흡수율을 유지시킬 수 없었다.However, the root cause of diabetes is that the small intestinal absorbent membrane does not readily absorb zinc. As the body tissues age, it becomes difficult to absorb nutrients and minerals, and westernized processed food-oriented eating habits inhibit zinc absorption, making it difficult to supply zinc into the body. When the intake was excessively low at 3% and the intake was increased to increase the absorption amount, the zinc absorption rate in the body could not be easily maintained because it accumulated in the body and exerted toxicity.
천연에 존재하는 모든 미네랄은 대부분 무기 화합물과 유기 화합물 등으로 되어 있어 흡수 이용률이 대단히 낮은 것이 큰 문제이다. 미네랄이 인체 내에 흡수되어 생체에서 이용되기 위해서는 반드시 미네랄 올리고 펩티드 형태로 변화되어야 한다.Most of the minerals present in nature are composed of inorganic compounds and organic compounds, so the use of very low absorption is a big problem. Minerals must be converted to mineral oligopeptide forms in order to be absorbed into the body and used in vivo.
좀 더 구체적으로 설명하면 우리가 섭취한 미네랄이 인체에 흡수되어 혈액까지 들어가기 위해서는 반드시 일단 물에 녹아서 무기 이온 상태가 되어야 한다. 물에 녹지 않는 안정된 화합물로 된 미네랄은 인체에 절대 흡수될 수 없는 것이다. 물에 용해되어 인체 내 혈액까지 흡수되었다 하더라도 미네랄의 최종 사용처인 세포까지 들어가기 위해서는 또 다른 변신이 필요하다.More specifically, the minerals we ingest must be dissolved in water and become inorganic ions in order to be absorbed by the human body and into the blood. Minerals with stable compounds that are insoluble in water can never be absorbed by the human body. Even if dissolved in water and absorbed into the blood of the human body, another transformation is required to enter the cell, the end-use of minerals.
일반 금속 미네랄이 그대로 세포 내로 흡수된다면 그 독성 때문에 세포는 파괴되어 버리므로 미네랄은 수용성 단백질인 올리고 펩티드에 의해 미네랄 올리고 펩티드 형태로 변화된 것만이 미네랄을 필요로 하는 세포 내로 들어갈 수 있는 것이다.If the normal metal mineral is absorbed into the cell as it is, the cell is destroyed because of its toxicity, so that only the mineral is changed into the form of the oligopeptide by the water-soluble protein oligopeptide can enter the cell that needs the mineral.
아연의 경우도 마찬가지로 산화 아연이나 염화 아연, 황산 아연 등 화합물 형태의 아연을 섭취하게 되면 이 중에 극히 일부분만이 십이지장에서 생성된 단백질의 부분 분해물인 올리고 펩티드와 결합하여, 즉 킬레이트화되어 아연 올리고 펩티드가 되는데 이렇게 생성된 2∼3%의 아연만이 생체에서 이용될 수 있는 것이다.In the case of zinc as well, ingesting zinc in the form of compounds such as zinc oxide, zinc chloride or zinc sulfate, only a small portion of the zinc binds to oligopeptides, which are partial decomposition products of proteins produced in the duodenum, ie, chelated to form zinc oligopeptides. Only 2 to 3% of the zinc thus produced can be used in vivo.
따라서 상기와 같이 제조된 킬레이트 아연은 킬레이트(chelate)화, 즉 단백질로 아연을 감싸는 형태의 조직이 이루어지므로 인체 내 세포의 거부감 없이 거의100%에 가깝게 생체 내에서 흡수 이용될 수 있게 되며 일반 아연에 비해 킬레이트 아연은 흡수 이용율이 약 30배나 높다고 보고되고 있다.Therefore, the chelated zinc prepared as described above is chelated, that is, the tissue is formed in the form of the protein wrapped in zinc, so that it can be absorbed and used in vivo almost 100% without rejection of cells in the human body. In comparison, chelated zinc has been reported to have an absorption rate of about 30 times higher.
최근 당뇨에 효과가 있다고 인기를 끌고 있는 누에 애벌레는 다른 천연물에 비해 아연을 엄청나게 많이 함유하고 있어 당뇨에 효과가 있음이 증명되고 있다. 누에 애벌레의 아연 함유량은 16mg/100g으로 1일 권장 섭취량 15mg과 비슷하나 건조물로 하루에 100g의 가루를 섭취하는 것은 곤란하므로 통상 1일 섭취량 5∼10g으로 계산해 보면 1일 0.8∼1.6mg의 아연 섭취로도 당뇨에 상당한 효과를 보고 있는 것을 알 수 있다.Recently, silkworm larvae, which have been popular for their effects on diabetes, have a huge amount of zinc compared to other natural products. The content of zinc in silkworm larvae is 16mg / 100g, which is similar to the recommended daily intake of 15mg, but it is difficult to consume 100g of powder per day as a dry one, so if you calculate the daily intake of 5-10g, 0.8-1.6mg of zinc intake per day It can be seen that also has a significant effect on diabetes.
따라서, 본 발명에서는 킬레이트 아연 중의 아연(Zn) 함량이 이론 당량치에 해당하는 6∼8중량%일 때의 비율을 기준으로 하여, 생식 타입 다류의 1회 섭취량을 40g으로 했을 때 아연을 최소한 0.8mg 이상 섭취할 수 있도록 하기 위해 0.03중량% 이상 첨가하여 아연의 최소 섭취량인 0.8mg 이상 함유하도록 하였으며, 5.0중량% 이상 첨가할 경우 킬레이트 아연의 신맛이 너무 강하게 느껴져 생식 타입 다류의 맛이 떨어지므로 5.0중량% 이하로 첨가하는 것이 바람직하며, 이는 킬레이트 아연의 순도 함량에 따라 변화시켜야 하고 함유 아연(Zn) 함량이 달라질 때는 비례하여 변경시킬 수 있다.Therefore, in the present invention, the zinc (Zn) content in the chelate zinc is based on the ratio of 6 to 8% by weight corresponding to the theoretical equivalent value, at least 0.8 mg of zinc when a single intake of the reproductive type polysaccharide is 40 g. In order to be able to ingest more than 0.03% by weight was added to contain more than 0.8mg of zinc, the minimum intake of zinc, when added over 5.0% by weight of chelate zinc so strong that the taste of the raw material type of tea is reduced 5.0 weight It is preferred to add it in% or less, which should be changed according to the purity content of chelated zinc and can be changed proportionally when the content of zinc (Zn) is changed.
또한 본 발명에서 조성물로서 배합되는 뽕잎은 예부터 전통적으로 당뇨에 효과가 있어 사용되어 오던 천연물로서, 농촌진흥청 농업과학기술원 잠사곤충부와 경희대 동서의학 대학원에서 연구한 결과에 의하면 뽕잎은 다음과 같은 효과가 있다고 한다.In addition, mulberry leaves formulated as a composition in the present invention is a natural product that has been used since traditionally effective for diabetes, according to the results of research at the Rural Development Administration Agricultural Science and Technology Institute Sasa insects and Kyung Hee University East-West Medical Graduate School It is said to be.
뽕잎 속에는 혈당치를 개선하는 기능이 있는 데옥시노지리마이신 (Deoxynojirimycin)이 다량 함유되어 있는 것으로 밝혀져 있는데, 뽕잎속의 데옥시노지리마이신은 음식물의 다당류를 단당류로 분해하는 효소인 알파-글루코시다제의 활성을 억제하여 전분이 한꺼번에 단당류로 분해되는 것을 막아 혈당의 일시적인 상승을 억제하는 것으로 알려져 있다.It is found that mulberry leaves contain a large amount of deoxynojirimycin, which has a function of improving blood sugar levels.Deoxynojirimycin in mulberry leaves is an enzyme of alpha-glucosidase, an enzyme that breaks down polysaccharides from food into monosaccharides. It is known to suppress the temporary rise of blood sugar by inhibiting activity to prevent starch from being broken down into monosaccharides at once.
또한 상기 누에 애벌레에서 명시한 바와 같이 누에 애벌레가 먹는 뽕잎에는 아연이 풍부하여 누에 애벌레의 몸 속에 아연을 축적시킬 수 있었던 것이다.In addition, as indicated in the silkworm larvae, mulberry leaves eaten by the silkworm larvae were rich in zinc, which was able to accumulate zinc in the body of the silkworm larvae.
따라서 본 발명에서는 뽕잎의 혈당 강하 효과를 함께 이용하기 위해 첨가하였지만, 0.5중량% 이하로 첨가하면 상기 뽕잎의 이용 효과가 미약하며 5.0중량% 이상 첨가할 경우 뽕잎 고유의 향이 튀게 되어 생식 타입 다류의 풍미를 저하시키므로 0.5∼5.0중량%의 범위로 첨가하는 것이 바람직하다.Therefore, in the present invention, but added to use the blood sugar lowering effect of the mulberry leaves, when added to less than 0.5% by weight is the use effect of the mulberry leaves is weak and when added to more than 5.0% by weight, the unique flavor of mulberry leaves splashes the flavor of the reproductive type tea Since it lowers, it is preferable to add in 0.5 to 5.0weight% of a range.
한편, 본 발명의 주요 조성물인 발아 현미란 현미를 싹틔운 것으로 발아 과정 중 전에 없던 특이한 약효 성분들이 새로 생겨나거나 현저히 증가하게 되어, 아라비녹시란, 감마오리자놀, 클로로피린, SOD, 활성화된 섬유소, 비타민류, 미네랄류 등이 새로 생겨나거나 증가됨으로 쾌변, 에너지 대사 촉진, 비만, 혈액 순환, 자연 치유력 증진 등의 효능이 있는 것으로 알려졌다.Meanwhile, germinated brown rice, which is the main composition of the present invention, sprouts brown rice, and new and unusually active ingredients that were not present during the germination process are newly formed or increased significantly, such as arabinoxylan, gamma-orizanol, chloropyrin, SOD, activated fiber, It is known that vitamins and minerals are newly formed or increased, such as eccentricity, energy metabolism promotion, obesity, blood circulation, and natural healing.
따라서 본 발명에서는 발아 현미를 59.0중량% 이상 첨가하여 그 효능을 충분히 이용하도록 하였으나 다른 조성물과의 맛의 조화를 고려하여 83.0중량% 이하로 첨가하는 것이 바람직하며, 특히 79.58중량%로 첨가하는 것이 가장 바람직하다.Therefore, in the present invention, 59.0% by weight or more of germinated brown rice is added to fully utilize the efficacy, but it is preferable to add 83.0% by weight or less in consideration of the balance of taste with other compositions, and especially it is added at 79.58% by weight. desirable.
발아 보리 또한 보리를 싹틔운 것으로서 섬유질, 칼슘, 철분, 비타민 B군 등이 함유되어 있어 설사, 당뇨, 피부, 변비, 혈액 순환 불량 등에 효능이 있어 1.0중량% 이상으로 첨가하되 8.0중량%를 초과할 경우 보리 섬유질 특유의 점성이 너무 강해지므로 상기 범위내로 첨가하는 것이 바람직하며, 특히 5.0중량%로 첨가하는 것이 가장 바람직하다.Germinated barley is also sprouting barley and contains fiber, calcium, iron, and vitamin B group. It is effective in diarrhea, diabetes, skin, constipation and poor blood circulation. In this case, since the viscosity peculiar to barley fiber becomes too strong, it is preferable to add it within the above range, and it is most preferable to add at 5.0% by weight.
발아 검정콩은 단백질, 아미노산, 필수지방산, 레시틴, 비타민 A, B1, B2, 니아신, 미네랄 등이 함유되어 있으며 관절염, 신장병, 위장병, 변비, 이뇨, 불면증 등에 효과가 있다. 따라서 최소한의 효과를 나타낼 수 있는 0.1중량% 이상으로 첨가하되 가격 상승의 측면을 고려하여 0.5중량% 이하로 첨가하는 것이 바람직하며, 그 중 0.3중량%로 첨가하는 것이 가장 바람직하다.Germinated black soybeans contain protein, amino acids, essential fatty acids, lecithin, vitamins A, B 1 , B 2 , niacin, and minerals, and are effective in arthritis, kidney disease, gastrointestinal diseases, constipation, diuresis and insomnia. Therefore, at least 0.1% by weight may be added, which may exhibit a minimum effect, but is preferably added at 0.5% by weight or less, and most preferably, 0.3% by weight.
발아 율무는 다른 곡류에 비하여 단백질과 지방이 조금 많은 것이 특징인데 탄수화물은 대부분 찰기가 있는 녹말로 구성되어 있다. 이외에도 지방, 비타민 B1, B2, 칼슘, 철분 등이 함유되어 있어 당뇨, 고혈압, 이뇨, 체중 조절, 신경통 등에 효과가 있는 것으로 알려져 있다. 발아 율무 역시 최소한의 영양적 효과를 고려하여 0.05중량% 이상으로 첨가하되 이것 역시 가격 상승의 경제적 측면을 고려하여 0.3중량% 이하로 첨가하는 것이 바람직하며, 0.2중량%로 첨가하는 것이 가장 바람직하다.Germination rate is slightly higher in protein and fat than other grains. Most carbohydrates are made of cold starch. In addition, it contains fat, vitamin B 1 , B 2 , calcium, iron, etc. It is known to be effective in diabetes, hypertension, diuresis, weight control, neuralgia. Germination rate is also added to 0.05% by weight or more in consideration of the minimum nutritional effect, it is also preferably added to 0.3% by weight or less in consideration of the economic aspect of the price increase, it is most preferable to add in 0.2% by weight.
발아 수수에는 탄수화물, 단백질, 지방, 비타민 B군, 미네랄, 섬유소 등이 함유되어 있으며 심혈관계 및 소화 촉진, 약물 해독 등에 좋은 장점이 있다. 이 또한 0.5중량% 이하로 첨가할 경우 그 효능의 발현이 미약하므로 0.5중량% 이상 첨가하지만 전체 조성물의 조화를 고려하여 1.5중량% 이하로 첨가하는 것이 바람직하며, 1.0중량%로 첨가하는 것이 가장 바람직하다.Germinated sorghum contains carbohydrates, proteins, fats, B vitamins, minerals, and fiber, and has good benefits in cardiovascular and digestion and drug detoxification. In addition, when added to 0.5% by weight or less, since the expression of its efficacy is weak, it is added by 0.5% by weight or more. Do.
발아 옥수수는 탄수화물, 지방산, 레시틴, 트레오닌 등이 주요 함유 성분으로 이뇨, 신장병, 당뇨, 방광염 등에 효과가 있어 0.5중량% 이상 첨가하되 5.0중량% 이상으로 첨가할 경우 가격이 비싸지므로 상기 범위내로 첨가하는 것이 바람직하며, 3.0중량%로 첨가하는 것이 가장 바람직하다.Germinated corn is a carbohydrate, fatty acid, lecithin, threonine, etc. are the main ingredients of diuretics, kidney disease, diabetes, cystitis, etc. are effective to add more than 0.5% by weight, but if added in more than 5.0% by weight because the price is added within the above range Preference is given to adding, most preferably at 3.0% by weight.
발아 차조에는 주로 전분, 환원당 등의 탄수화물과 단백질, 지방, 비타민 B군 및 칼슘, 철 등이 주로 함유되어 있고 당뇨병, 빈뇨, 산후회복, 어린이 발육 촉진 등에 특히 이로운데, 0.2중량%보다 적을 경우 효능이 미약하고 또한 이것 역시 2.0중량% 이상으로 첨가하게 되면 가격 상승이 초래되므로 0.2중량%∼2.0중량%의 범위 내로 첨가하는 것이 바람직하며 특히 1.0중량%로 첨가하는 것이 가장 바람직하다.Germinated tea contains mainly carbohydrates such as starch and reducing sugars, protein, fat, B vitamins, calcium and iron, and is particularly beneficial for diabetes, urinary frequency, postpartum recovery, and promoting children's development. This feeble addition and addition of more than 2.0% by weight also leads to an increase in price, so it is preferably added within the range of 0.2% by weight to 2.0% by weight, most preferably 1.0% by weight.
발아 팥은 사포닌, 콜린, 지방산, 비타민 B1, 섬유질 등이 주요 함유 성분으로서 신장병, 위장병, 에너지 대사 촉진, 숙취 해독, 변비 등에 좋은 효과가 있다. 따라서 전체적인 조성물의 첨가량 및 향미의 조화를 고려하여 0.3중량%∼0.8중량%의 범위로 첨가하는 것이 바람직하며 그 중 0.5중량%로 첨가하는 것이 가장 바람직하다.Germinated red beans are saponin, choline, fatty acids, vitamin B 1 , fiber, etc. The main components are kidney disease, gastrointestinal disease, energy metabolism promotion, hangover detoxification, constipation and so on. Therefore, it is preferable to add in the range of 0.3% by weight to 0.8% by weight in consideration of the balance of the addition amount and flavor of the overall composition, and most preferably, 0.5% by weight.
발아 검정깨에는 단백질, 지방, 비타민 A, 비타민 C, 칼슘, 인, 철 등이 함유되어 있어 당뇨병, 신장병, 노이로제, 허약자, 간장병, 결핵 등에 효과가 있는것으로 알려져 있는데, 0.05중량% 이하로 첨가할 경우 그 효능이 미약하고 0.35중량% 이상 첨가하면 가격이 비싸지므로 상기 범위내로 첨가하는 것이 바람직하며 특히 0.2중량%로 첨가하는 것이 가장 바람직하다.Germinated black sesame seeds contain protein, fat, vitamin A, vitamin C, calcium, phosphorus and iron, which are known to be effective in diabetes, kidney disease, neurosis, weakness, liver disease and tuberculosis. In this case, since the efficacy is weak and 0.35% by weight or more is added because the price is high, it is preferable to add within the above range, and most preferably added in 0.2% by weight.
발아 밀은 식물성 섬유와 비타민 E가 풍부하여 위장을 튼튼하게 하고 노화 방지에도 효과가 있으며 비타민 E의 항산화 작용과 혈중 콜레스테롤치를 떨어드리는 리놀레산의 작용이 있어 동맥경화증을 예방하며 신경을 안정시키는 효능이 있다.Germinated wheat is rich in vegetable fiber and vitamin E, which strengthens the stomach and prevents aging. It also has the antioxidant effect of vitamin E and linoleic acid, which lowers blood cholesterol levels, thus preventing atherosclerosis and stabilizing nerves. .
발아 밀 역시 0.1중량% 이하로 첨가할 경우 발아 밀의 장점을 이용하는 효과가 미약하고 0.3중량% 이상 첨가하면 가격이 비싸지므로 상기 범위내로 첨가하는 것이 바람직하며 0.2중량%로 첨가하는 것이 가장 바람직하다.Germinated wheat is also less than 0.1% by weight, the effect of using the advantage of germinated wheat is weak and the addition of more than 0.3% by weight is expensive, it is preferable to add within the above range, it is most preferred to add 0.2% by weight.
케일은 탄수화물, 단백질, 비타민류, 칼슘, 철, 엽록소 등이 함유되어 있고 항암, 동맥경화, 간장병, 위장, 비만, 신장병, 빈혈 등에 효능이 있으므로 첨가하는 것이 바람직하다.Kale contains carbohydrates, proteins, vitamins, calcium, iron, chlorophyll, and the like, and is effective in anticancer, arteriosclerosis, liver disease, gastrointestinal, obesity, kidney disease, and anemia.
명일엽은 비타민 B군, 플라보노이드, 루테오닌, 이소쿠엘치트린 등이 주요 함유성분으로서 고혈압, 빈혈, 당뇨, 신경통, 이뇨, 피로 회복의 효능이 있으므로 첨가하는 것이 바람직하다.Myeongilyeop is preferably added because vitamin B group, flavonoids, luteonine, isocelchitrin, etc. are the main ingredients of high blood pressure, anemia, diabetes, neuralgia, diuresis, fatigue recovery.
다시마에는 비타민류, 칼륨, 칼슘, 철, 요오드 등이 함유되어 있고 고혈압, 신장병, 동맥 경화, 당뇨, 위궤양, 심장병, 변비, 류마티스, 악성빈혈 등에 효능이 있으므로 첨가하는 것이 바람직하다.The kelp contains vitamins, potassium, calcium, iron, iodine and the like, and is effective in hypertension, kidney disease, atherosclerosis, diabetes, gastric ulcer, heart disease, constipation, rheumatism, pernicious anemia, and so on.
미역은 단백질, 비타민 A, B1, B2, C, K와 칼슘, 인, 철 등이 함유되어 있고 변비, 비만, 신진대사 촉진, 조혈 작용의 효능이 있으므로 첨가하는 것이 바람직하다.Seaweed contains protein, vitamins A, B 1 , B 2 , C, K and calcium, phosphorus, iron, etc., and it is preferable to add constipation, obesity, metabolism promotion, hematopoietic effect.
김은 비타민 A, B1, B2, C, K와 칼슘, 인 등이 주요 함유 성분으로 위, 십이지장 궤양, 식욕부진, 간장병, 고혈압 등에 효능이 있으므로 첨가하는 것이 바람직하다.Seaweed is a vitamin A, B 1 , B 2 , C, K and calcium, phosphorus, etc. are the main ingredients are effective in stomach, duodenal ulcers, anorexia, liver disease, high blood pressure, etc. It is preferable to add.
쑥에는 비타민 A, K, C와 치네올이 함유되어 있어 해열, 진통, 해독, 구충, 혈압강하 등에 효능이 있으므로 첨가하는 것이 바람직하다.Mugwort contains vitamins A, K, C and cineol, so it is effective in antipyretic, analgesic, detoxification, hookworm, lowering blood pressure and so on.
표고버섯에는 탄수화물, 단백질, 지방, 비타민, 칼륨, 칼슘, 인, 철 등이 함유되어 있으며 항암, 고혈압, 심장병, 당뇨, 뇌졸중, 뇌신경 강화 등의 효능이 있으므로 첨가하는 것이 바람직하다.Shiitake mushrooms contain carbohydrates, proteins, fats, vitamins, potassium, calcium, phosphorus, iron, etc., and it is preferable to add them because they are effective in anticancer, hypertension, heart disease, diabetes, stroke, and nerve strengthening.
당근은 탄수화물, 단백질, 비타민류, 칼륨, 칼슘, 인, 철 등이 함유되어 있어 심장병, 저혈압, 신장병, 설사, 소화불량, 식욕부진, 치질, 대장염, 천식 등에 효능이 있으므로 첨가하는 것이 바람직하다.Carrots contain carbohydrates, proteins, vitamins, potassium, calcium, phosphorus, iron and the like, so they are effective for heart disease, hypotension, kidney disease, diarrhea, indigestion, anorexia, hemorrhoids, colitis, asthma, etc.
솔잎은 비타민 A, K, C와 철분, 효소 등이 주로 함유되어 있으며 고혈압, 저혈압, 빈혈, 조혈, 정혈작용, 강장, 콜레스테롤 저하에 효능이 있으므로 첨가하는 것이 바람직하다.Pine needles contain vitamins A, K, C and iron, enzymes, etc., and high blood pressure, hypotension, anemia, hematopoiesis, antistatic action, tonic, cholesterol-lowering is preferable to add.
감초는 글리시리진이 주요 함유 성분으로 해독 및 알레르기, 위장병에 효능이 있으므로 첨가하는 것이 바람직하다.Licorice is preferred because glycyrrhizin is the main ingredient and is effective in detoxification, allergy and gastrointestinal diseases.
효모에는 아미노산, 미네랄, 비타민 등이 함유되어 있으며 빈혈, 소화촉진, 아미노산 공급 등의 역할을 하므로 첨가하는 것이 바람직하다.Yeast contains amino acids, minerals, vitamins, and the like, so it is preferable to add anemia, promote digestion, and supply amino acids.
상기 재료들은 영양적 균형 및 맛의 조화, 가격 상의 경제적 측면을 고려하여 그 첨가 범위를 결정하였으므로 상기 기재한 첨가 범위 이내로 첨가하는 것이 바람직하다.Since the ingredients have been determined in consideration of the nutritional balance, the harmony of taste, and the economical aspect of the price, it is preferable to add the ingredients within the above-described addition range.
이외에도 식이 섬유, 비타민 B1, 비타민 B6, 비타민 C, 칼슘 등도 당뇨를 호전시키는데 직간접적으로 효과가 있어 널리 사용되어 오던 성분들로 킬레이트 아연과 함께 첨가함으로써 상승 효과를 유발시킬 수 있는 성분들이므로 본 발명에 조성물로서 첨가하였으며, 그 첨가량은 통상적인 1일 섭취량과 생식 타입 차 조성물의 전체적인 향미의 조화를 고려하여 상기 기재한 범위 내로 첨가하는 것이 바람직하다.In addition, dietary fiber, vitamin B 1 , vitamin B 6 , vitamin C, calcium, etc. are also directly or indirectly effective in improving diabetes. These ingredients have been widely used. It was added to the present invention as a composition, and the amount is preferably added within the above-described range in consideration of the balance between the general daily intake and the overall flavor of the raw type tea composition.
또한 로얄젤리, 스테비오 사이드 등을 첨가하여 생식 타입 차 조성물의 영양과 맛을 보강할 수 있다.Royal jelly and stevioside may also be added to enhance the nutrition and taste of the raw tea composition.
본 발명에 따른 차 조성물의 정확한 1일 섭취량은 투여 방법이나 치료 조건에 따라 상이하나 성인의 경우 40g 용량씩 1일 1∼2회 섭취하는 것이 바람직하다.The exact daily intake of the tea composition according to the present invention is different depending on the administration method or treatment conditions, but in adults, it is preferable to take 40g dose once or twice a day.
이하 실시예를 통하여 본 발명을 상세하게 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail with reference to the following Examples.
[실시예 1]Example 1
발아 현미 79.58중량%, 발아 보리 5.0중량%, 발아 검정콩 0.3중량%, 발아 율무 0.2중량%, 발아 수수 1.0중량%, 발아 옥수수 3.0중량%, 발아 차조 1.0중량%, 발아 팥 0.5중량%, 발아 검정깨 0.2중량%, 발아밀 0.2중량%, 킬레이트 아연 0.5중량%, 뽕잎 1.0중량%, 케일 0.2중량%, 명일엽 0.2중량%, 다시마 1.0중량%, 미역 1.0중량%, 김 0.1중량%, 쑥 0.5중량%, 표고 버섯 0.2중량%, 당근 0.2중량%, 솔잎 0.2중량%, 미강 1.0중량%, 감자 0.2중량%, 메밀 0.2중량%, 늙은 호박 0.2중량%, 양배추 0.2중량%, 무 0.2중량%, 석이 버섯 0.2중량% 등의 재료를 각각 익히지 않고 생으로 건조하여 분말로 한 것과 로얄 젤리 0.1중량%, 감초 0.8중량%, 젖산 효모 0.8중량%, 스테비오 사이드 0.02중량% 각각을 50메쉬 체로 통과시킨 후 V형 혼합기에 넣고 30분간 잘 혼합하여 1회 섭취 분량인 40g으로 포장한다.Germinated brown rice 79.58 wt%, germinated barley 5.0 wt%, germinated black soybean 0.3 wt%, germination rate 0.2 wt%, germinated sorghum 1.0 wt%, germinated corn 3.0 wt%, germinated green tea 1.0 wt%, germinated red bean 0.5 wt%, germination black 0.2% by weight of sesame seeds, 0.2% by weight of germination, 0.5% by weight of chelated zinc, 1.0% by weight of mulberry leaves, 0.2% by weight of kale, 0.2% by weight of kelp leaves, 1.0% by weight of kelp, 1.0% by weight of seaweed, 0.1% by weight of seaweed, 0.5 weight of wormwood %, Shiitake mushroom 0.2%, Carrot 0.2%, Pine needles 0.2%, Rice bran 1.0%, Potato 0.2%, Buckwheat 0.2%, Old pumpkin 0.2%, Cabbage 0.2%, Radish 0.2% Ingredients such as 0.2% by weight of mushrooms, dried, raw, powdered, 0.1% by weight of royal jelly, 0.8% by weight of licorice, 0.8% by weight of lactic acid yeast, and 0.02% by weight of stevioside were passed through a 50 mesh sieve. Put it into the mixer and mix well for 30 minutes. Pack it in 40g serving size.
[실시예 2]Example 2
발아 현미 77.95중량%, 발아 보리 5.0중량%, 발아 검정콩 0.3중량%, 발아 율무 0.2중량%, 발아 수수 1.0중량%, 발아 옥수수 3.0중량%, 발아 차조 1.0중량%, 발아 팥 0.5중량%, 발아 검정깨 0.2중량%, 발아밀 0.2중량%, 킬레이트 아연 0.5중량%, 뽕잎 1.0중량%, 케일 0.2중량%, 명일엽 0.2중량%, 다시마 1.0중량%, 미역 1.0중량%, 김 0.1중량%, 쑥 0.5중량%, 표고 버섯 0.2중량%, 당근 0.2중량%, 솔잎 0.2중량%, 미강 1.0중량%, 감자 0.2중량%, 메밀 0.2중량%, 늙은 호박 0.2중량%, 양배추 0.2중량%, 무 0.2중량%, 석이 버섯 0.2중량% 등을 각각 익히지 않고 생으로 건조하여 분말로 한 것과 로얄 젤리 0.1중량%, 감초 0.8중량%, 젖산 효모 0.8중량%, 스테비오 사이드 0.02중량%, 비타민 B10.01중량%, 비타민 B60.02중량%, 비타민 C 0.1중량%, 콩섬유질 1.0중량%, 유청칼슘 0.5중량% 각각을 50메쉬 체로 통과시킨 후 V형 혼합기에 넣고 30분간 잘 혼합하여 1회 섭취 분량인 40g으로 포장한다.Germinated brown rice 77.95 wt%, germinated barley 5.0 wt%, germinated black soybean 0.3 wt%, germination rate 0.2 wt%, germinated sorghum 1.0 wt%, germinated corn 3.0 wt%, germinated green tea 1.0 wt%, germinated red bean 0.5 wt%, germination black 0.2% by weight of sesame seeds, 0.2% by weight of germination, 0.5% by weight of chelated zinc, 1.0% by weight of mulberry leaves, 0.2% by weight of kale, 0.2% by weight of kelp leaves, 1.0% by weight of kelp, 1.0% by weight of seaweed, 0.1% by weight of seaweed, 0.5 weight of wormwood %, Shiitake mushroom 0.2%, Carrot 0.2%, Pine needles 0.2%, Rice bran 1.0%, Potato 0.2%, Buckwheat 0.2%, Old pumpkin 0.2%, Cabbage 0.2%, Radish 0.2% 0.2% by weight of mushrooms, etc., not dried, powdered and dried, 0.1% by weight of royal jelly, 0.8% by weight licorice, 0.8% by weight of lactic acid yeast, 0.02% by weight of stevioside, 0.01% by weight of vitamin B 1 , and vitamin B 6 0.02 Type V horn after passing 50% by weight, 0.1% by weight of vitamin C, 1.0% by weight of soy fiber, 0.5% by weight of whey calcium 30 minutes into groups mixed well and packed into a single intake volume 40g.
[실시예 3]Example 3
발아 현미 79.785중량%, 킬레이트 아연 0.03중량%, 뽕잎 0.5중량%, 비타민 B10.005중량%, 비타민 B60.01중량%, 비타민 C 0.05중량%, 콩섬유질 0.5중량%, 유청칼슘 0.2중량%로 첨가한 것을 제외하고는 상기 실시예 2와 동일한 방법으로 제조하였다.Germinated brown rice added at 79.785%, chelated zinc 0.03%, mulberry leaf 0.5%, vitamin B 1 0.005%, vitamin B 6 0.01%, vitamin C 0.05%, soy fiber 0.5%, whey calcium 0.2% It was prepared in the same manner as in Example 2 except for the one.
[실시예 4]Example 4
발아 현미 71.47중량%, 킬레이트 아연 1.0중량%, 뽕잎 3.0중량%, 비타민 B10.03중량%, 비타민 B60.08중량%, 비타민 C 0.5중량%, 콩 섬유질 2.0중량%, 유청 칼슘 3.0중량%로 첨가한 것을 제외하고는 상기 실시예 2와 동일한 방법으로 제조하였다.Add 71.47% germinated brown rice, 1.0% chelate zinc, 3.0% mulberry leaf, 0.03% vitamin B 1 , 0.08% vitamin B 6 , 0.5% vitamin C, 2.0% soy fiber, 3.0% whey calcium. It was prepared in the same manner as in Example 2 except for the one.
[실시예 5]Example 5
발아 현미 59.93중량%, 킬레이트 아연 5.0중량%, 뽕잎 5.0중량%, 비타민 B10.05중량%, 비타민 B60.1중량%, 비타민 C 1.0중량%, 콩섬유질 5.0중량%, 유청칼슘 5.0중량%로 첨가한 것을 제외하고는 상기 실시예 2와 동일한 방법으로 제조하였다.Germinated brown rice 59.93%, chelated zinc 5.0%, mulberry leaf 5.0%, vitamin B 1 0.05%, vitamin B 6 0.1%, vitamin C 1.0%, soy fiber 5.0%, whey calcium 5.0% It was prepared in the same manner as in Example 2 except for the one.
[비교예 1]Comparative Example 1
발아 현미를 81.08중량%로 첨가하고 킬레이트 아연, 뽕잎을 첨가하지 않은것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1 except that the germinated brown rice was added at 81.08% by weight and no chelated zinc and mulberry leaves were added.
[비교예 2]Comparative Example 2
발아 현미 54.78중량%, 킬레이트 아연 7.0중량%, 뽕잎 7.0중량%, 비타민 B10.1중량%, 비타민 B60.2중량%, 비타민 C 2.0중량%, 콩 섬유질 3.0중량%, 유청 칼슘 7.0중량%로 첨가한 것을 제외하고는 상기 실시예 2와 동일한 방법으로 제조하였다.Germinated brown rice 54.78%, chelated zinc 7.0%, mulberry leaf 7.0%, vitamin B 1 0.1%, vitamin B 6 0.2%, vitamin C 2.0%, soy fiber 3.0%, whey calcium 7.0% by weight It was prepared in the same manner as in Example 2 except for the one.
[비교예 3]Comparative Example 3
발아 현미 80.354중량%, 킬레이트 아연 0.01중량%, 뽕잎 0.3중량%, 비타민 B10.001중량%, 비타민 B60.005중량%, 비타민 C 0.01중량%, 콩 섬유질 0.3중량%, 유청 칼슘 0.1중량%로 첨가한 것을 제외하고는 상기 실시예 2와 동일한 방법으로 제조하였다.Germinated brown rice 80.354%, chelated zinc 0.01%, mulberry leaf 0.3%, vitamin B 1 0.001%, vitamin B 6 0.005%, vitamin C 0.01%, soy fiber 0.3%, whey calcium 0.1% It was prepared in the same manner as in Example 2 except for the one.
상기 실시예 1, 2, 3, 4, 5 및 비교예 1, 2, 3의 방법으로 제조한 생식 타입 차 조성물을 남성 당뇨 환자 40명을 8그룹으로 나누어 1회 40g의 분량으로 1일 2회씩 3개월간 섭취하게 하여 섭취전과 후의 혈당치를 비교하여 그 결과의 평균값을 표 1에 나타내었다.The reproductive type tea composition prepared by the method of Examples 1, 2, 3, 4, 5 and Comparative Examples 1, 2 and 3 was divided into 8 groups of 40 male diabetic patients, twice a day in an amount of 40 g once a day. Intake for three months compared the blood glucose level before and after ingestion and the average value of the results are shown in Table 1.
상기 표 1의 결과에 의하면 킬레이트 아연 등의 재료를 첨가한 생식 타입의 차 조성물을 섭취한 그룹에서는 혈당 수치의 저하가 현저하게 나타났으며 첨가량에 비례하여 감소량의 폭이 증가하였다. 또한 비타민류와 콩섬유질, 유청 칼슘을 추가로 첨가한 실시예 2에서 혈당량 감소치가 더욱 커져 상승 작용을 한 것으로 나타났다. 그러나 킬레이트 아연 및 뽕잎 등의 재료를 첨가하지 않은 비교예 1을 복용한 그룹 D의 경우에도 적은 양의 혈당치 감소가 있었는데 이는 생식 자체의 장점으로 인한 것으로서 당뇨병의 치료 효과로 보기는 어려운 것으로 판단되었다.According to the results of Table 1, in the group ingesting the reproductive type tea composition to which the chelating zinc and other ingredients were added, the blood sugar level was remarkably decreased and the width of the decrease was increased in proportion to the amount added. In addition, in Example 2 with the addition of vitamins, soybean fiber, and whey calcium, it was shown that the decrease in blood glucose level was increased and synergistic effect. However, in the case of Group D taking Comparative Example 1 without addition of chelating zinc and mulberry leaves, there was a small amount of blood sugar reduction, which is due to the advantages of reproduction itself, and thus, it was judged that it was difficult to treat as a therapeutic effect of diabetes.
또한 비교예 2에서는 킬레이트 아연, 뽕잎, 비타민 등이 첨가량이 제일 많음에도 불구하고 혈당치 감소량이 실시예 4, 5의 경우보다 오히려 적은 것으로 나타났는데 이를 조사해 본 결과 상기 재료들의 과량 첨가로 인해 생식 타입 차의 맛이 저하되어 실험자들이 제대로 섭취하지 않은 결과 때문인 것으로 나타났다.In Comparative Example 2, although the amount of chelated zinc, mulberry leaf, vitamins, etc. was the most added, the decrease in blood sugar level was found to be smaller than that of Examples 4 and 5. It was found that the result of poor taste was due to the result that the experimenter did not eat properly.
실시예 4, 실시예 5의 경우도 효능은 우수하지만 실시예 1과 실시예 2 및 실시예 3에 비해 맛이 떨어져 실험자들이 섭취하기 어려워했던 것으로 조사되었다.In the case of Example 4 and Example 5, the efficacy was also excellent, but the taste was poor compared to Example 1, Example 2 and Example 3, it was investigated that it was difficult for the experimenters to ingest.
따라서 킬레이트 아연 및 뽕잎, 비타민 등의 재료를 첨가하기 전과 후의 생식 타입 차의 기호도 차이를 비교하기 위하여 10명의 전문 패널에게 5점 척도법으로 관능검사를 실시하여 그 결과의 평균값을 표 2에 나타내었다.Therefore, in order to compare the difference in preference between reproductive type tea before and after adding chelated zinc, mulberry leaf, and vitamins, 10 panelists performed sensory tests on a 5-point scale and the average values of the results are shown in Table 2.
표 2에 따르면 본 발명에 따른 조성물과 기존의 생식 타입 차 제품간에 맛과 향의 차이는 크지 않은 것으로 나타났지만 전체적으로 볼 때 킬레이트 아연, 뽕잎, 비타민 등의 첨가량이 증가할수록 재료 특유의 신맛과 강한 냄새가 전체적인 향미의 질을 감소시켜 기호도가 떨어지는 것으로 나타났다.According to Table 2, the difference in taste and aroma between the composition according to the present invention and the conventional reproductive type tea products was not significant, but as a whole, the addition of chelate zinc, mulberry leaves, vitamins and the like increased the unique taste and strong smell of the ingredients. Decreases the quality of the overall flavor and appears to be less palatable.
특히 비교예 2의 경우 맛과 향이 상당히 좋지 않아서 제품으로서의 가치가 없는 것으로 판단되었고 실시예 4, 실시예 5는 기호도는 보통이지만 혈당 감소량의 측면을 고려할 경우 심각한 당뇨 환자에게는 유용할 것으로 판단되었다.Particularly, in Comparative Example 2, since the taste and aroma were not very good, it was judged to be of no value as a product. Example 4 and Example 5 had moderate palatability, but were considered to be useful for serious diabetic patients considering the reduction in blood glucose.
따라서 실시예 1과 실시예 2의 경우가 혈당 감소량도 우수하며 기호도도 좋은 것으로 나타나 최적 실시예임을 확인할 수 있었다.Therefore, the case of Example 1 and Example 2 was also shown to be the best example of the excellent blood sugar reduction amount and also good preference.
이상에서 본 바와 같이 본 발명에 따른 항당뇨 기능의 생식 타입 차 조성물은 기존 생식 타입 차의 맛과 향에서 큰 차이가 없으면서 당뇨 치료 기능이 강화된 우수한 항당뇨 기능의 생식 타입 차 조성물임을 확인할 수 있었다.As described above, the reproductive type tea composition of the anti-diabetic function according to the present invention was confirmed that the reproductive type tea composition of the excellent anti-diabetic function with enhanced diabetes treatment function without significant difference in taste and aroma of the existing reproductive type tea. .
상기한 바와 같이 이루어지는 본 발명에 의하면, 생식 타입의 차에 세포의 거부감 및 부작용 없이 거의 100%에 가깝게 생체 내에서 흡수 이용될 수 있게 한 킬레이트 아연을 첨가함으로써, 당뇨 환자들의 체내 아연 흡수를 높여 인슐린 활성화에 따른 당뇨 증상을 완화시킬 수 있으며, 또한 당뇨에 효과가 있는 뽕잎, 식이 섬유, 비타민 B1, 비타민 B6, 비타민 C, 칼슘 등을 함께 첨가시켜 상승 효과를 가져와 당뇨에 유익한 생식 타입의 차 조성물을 제공할 수 있다.According to the present invention made as described above, by adding chelated zinc to the reproductive type tea, which can be absorbed and used in vivo almost 100% without cell rejection and side effects, insulin absorption is increased by diabetic patients. It is possible to alleviate the symptoms of diabetes caused by activation, and also adds mulberry leaf, dietary fiber, vitamin B 1 , vitamin B 6 , vitamin C and calcium, etc. A composition can be provided.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000062365A KR100325584B1 (en) | 2000-10-23 | 2000-10-23 | The composites of raw-type tea with anti-diabetic function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000062365A KR100325584B1 (en) | 2000-10-23 | 2000-10-23 | The composites of raw-type tea with anti-diabetic function |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010016067A KR20010016067A (en) | 2001-03-05 |
KR100325584B1 true KR100325584B1 (en) | 2002-03-06 |
Family
ID=19694925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000062365A KR100325584B1 (en) | 2000-10-23 | 2000-10-23 | The composites of raw-type tea with anti-diabetic function |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100325584B1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030044273A (en) * | 2001-11-29 | 2003-06-09 | 우병하 | A composition for lowering the blood sugar level |
KR20030084021A (en) * | 2002-04-24 | 2003-11-01 | 이순재 | An antidiabetic composition comprising mulberry leaves and green tea powder |
KR100747650B1 (en) * | 2006-03-22 | 2007-08-08 | 조점화 | Tea composition containing natural plant extracts |
CN104247840A (en) * | 2014-10-05 | 2014-12-31 | 黄介兰 | Pumpkin tea capable of losing weight |
CN107509837A (en) * | 2016-06-16 | 2017-12-26 | 西昌学院 | A kind of preparation method of potato bitter buckwheat shaped tea |
CN109805380A (en) * | 2019-04-04 | 2019-05-28 | 黄国栋 | A kind of breakfast food production technology of integrated grain germ |
-
2000
- 2000-10-23 KR KR1020000062365A patent/KR100325584B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010016067A (en) | 2001-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6869621B2 (en) | Diet composition comprising raw foods and dietary fibers | |
Afzal et al. | Health benefits and importance of utilizing wheat and rye | |
KR101722481B1 (en) | functional cereal containing sweet potato chip, broccoli granule and dietary fiber for constipation improving and manufacturing method thereof | |
KR101632794B1 (en) | METHOD OF MANUFACTURING PILL COMPRISED OF Protaetia brevitarsis seulensis | |
KR100336644B1 (en) | The composites of raw-type tea with anti-obese function | |
KR20090067685A (en) | A instant cooked rice for diet and glycosuria | |
KR20040095949A (en) | Composition comprising herb with usage to prevent obeseness | |
KR100325584B1 (en) | The composites of raw-type tea with anti-diabetic function | |
KR20050047053A (en) | Meal substitutes based on brown rice and various nutritional ingredients | |
CN110638038A (en) | Medical formula nutritional meal replacement powder for controlling hyperglycemia and preparation method thereof | |
KR20210035592A (en) | galeusinialeul iyonghan biman haeso gineung-ui saengsigtaib cha joseongmul | |
KR100336650B1 (en) | The composites of raw-type tea with the function of activating the brain and promoting the growth | |
KR100329011B1 (en) | The composites of raw-type tea containing octacosanol | |
US4273794A (en) | Composition containing honey | |
KR20090081062A (en) | A diabetes pharmaceutical composition and manufacturing process thereof | |
KR100337005B1 (en) | The composites of raw-type tea fortified the function of reducing cholesterol and thrombi | |
CN1307826A (en) | Functional food and its use | |
KR100336646B1 (en) | The composites of raw-type tea containing arabinoxylane | |
KR100390095B1 (en) | Preparation method of gimchi with aloe gel | |
CN111406940A (en) | Dietary fiber composition and edible product | |
CN105981760A (en) | Selenium-enriched radix puerariae rice bread | |
KR20050111460A (en) | Hotteok dough containing nuts and hotteok making method using the hotteok dough | |
KR100450055B1 (en) | Food composition for improving physical constitution containing seeds of bean plants as main components, and food produced therefrom | |
KR20030073759A (en) | Natural Energy Pill | |
CN111543591A (en) | Mixed coarse cereals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
G15R | Request for early opening | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120208 Year of fee payment: 11 |
|
LAPS | Lapse due to unpaid annual fee |